SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

アジア太平洋地域の神経血管デバイス / インターベンショナル神経学市場

出版：Inkwood Research

ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET FORECAST 2021-2028アジア太平洋地域の神経血管デバイス / インターベンショナル神経学市場
種別英文調査報告書
出版Inkwood Research
出版年月2021年7 月
ページ数171
価格
シングルユーザライセンスUSD 1,250
マルチユーザライセンスUSD 1,500
エンタープライズライセンスUSD 2,000
–

このレポートへお問合せ　　　レポート目次

Inkwood Research「ASIA-PACIFIC NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET FORECAST」はアジア太平洋地域の神経血管デバイス / インターベンショナル神経学市場調査レポートです。KEY FINDINGSThe Asia-Pacific neurovascular devices / interventional neurology market growth is anticipated to progress at a CAGR of 5.29% during the forecast period, 2021-2028. The increasing geriatric population is the dominant factor fueling the market growth.MARKET INSIGHTSAustralia & New Zealand, India, China, Thailand, Indonesia, Japan, Vietnam, South Korea, and Rest of Asia-Pacific are evaluated for the Asia-Pacific neurovascular devices / interventional neurology market growth analysis. In India, due to the prevalence of neurovascular diseases, there are increased market demands. This is also attributed to the less preventive strategies and unorganized management for stroke. There is rising utilization of endovascular treatment techniques. The drastic adoption of endovascular coiling has led to a transition in interventional neuroradiology. Further, there is less awareness about stroke and even lesser awareness of neurovascular diseases in rural areas. Therefore, government initiatives are projected to influence market demands. In Australia, the market growth is accredited to increasing burn injury cases. As per the Australian Bureau of Statistics, more than 700,000 Australians have brain injuries. The prevalence is due to the geriatric population and misbalance in their mobility. Neurological disorders account for almost 20.5% of the total disability globally. With rising concerns, there has been a rise in the number of research institutes for neurological disorders. In Thailand, the number of Alzheimer’s patients is estimated to rise to 1,117,000 by 2030, thereby escalating market demands. According to the World Bank, the population is again rapidly. This increases the risk of neurological disorders like Alzheimer’s disease. Moreover, stroke is a major health burden in the country. Such factors make these countries conducive market for neurovascular devices. COMPETITIVE INSIGHTSSome of the prominent companies in the market include Microport Scientific Corporation, Penumbra Inc, Asahi Intecc, Memry Corporation, B Braun Melsungen AG, etc.Our report offerings include:• Explore key findings of the overall market• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions• Market Segmentation cater to a thorough assessment of key segments with their market estimations• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

目次


Table of Contents

TABLE OF CONTENTS1. RESEARCH SCOPE & METHODOLOGY1.1. STUDY OBJECTIVES1.2. SCOPE OF STUDY1.3. METHODOLOGY1.4. ASSUMPTIONS & LIMITATIONS2. EXECUTIVE SUMMARY2.1. MARKET SIZE & ESTIMATES2.2. MARKET OVERVIEW3. MARKET DYNAMICS3.1. KEY DRIVERS3.1.1. INCIDENCE OF NEUROVASCULAR CONDITIONS3.1.2. DEMAND FOR MINIMALLY INVASIVE PROCEDURES3.1.3. SIGNIFICANCE OF NEUROLOGICAL DISEASES IN GERIATRIC POPULATION3.1.4. PREVALENCE OF UNDERLYING DISEASE CONDITIONS 3.2. KEY RESTRAINTS3.2.1. EXORBITANT COST OF NEUROVASCULAR DEVICES3.2.2. LACK OF ADEQUATE NUMBER OF TRAINED NEUROSURGEONS4. KEY ANALYTICS4.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES MARKET4.2. KEY MARKET TRENDS4.3. PORTER’S FIVE FORCES ANALYSIS4.3.1. BUYERS POWER4.3.2. SUPPLIERS POWER4.3.3. SUBSTITUTION4.3.4. NEW ENTRY4.3.5. INDUSTRY RIVALRY4.4. OPPORTUNITY MATRIX4.5. VENDOR LANDSCAPE5. MARKET BY PRODUCT5.1. EMBOLIZATION DEVICES5.2. ACCESSORY DEVICES5.3. REVASCULARIZATION DEVICES5.4. THROMBECTOMY DEVICES5.5. EMBOLIC PROTECTION DEVICES6. MARKET BY APPLICATION6.1. ANEURYSM6.2. ISCHEMIC STROKE6.3. STENOSIS6.4. ARTERIOVENOUS MALFORMATION (AVM)6.5. OTHER APPLICATIONS7. GEOGRAPHICAL ANALYSIS7.1. ASIA-PACIFIC7.1.1. MARKET SIZE & ESTIMATES7.1.2. KEY GROWTH ENABLERS7.1.3. KEY CHALLENGES7.1.4. KEY PLAYERS7.1.5. COUNTRY ANALYSIS7.1.5.1. CHINA7.1.5.2. JAPAN7.1.5.3. AUSTRALIA & NEW ZEALAND7.1.5.4. INDIA7.1.5.5. SOUTH KOREA7.1.5.6. THAILAND7.1.5.7. INDONESIA7.1.5.8. VIETNAM7.1.5.9. REST OF ASIA-PACIFIC8. COMPETITIVE LANDSCAPE8.1. KEY STRATEGIC DEVELOPMENTS8.1.1. MERGERS & ACQUISITIONS8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS8.1.3. PARTNERSHIPS & AGREEMENTS8.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES8.2. COMPANY PROFILES8.2.1. ACANDIS GMBH8.2.2. ASAHI INTECC8.2.3. B BRAUN MELSUNGEN AG8.2.4. INTEGER HOLDINGS CORPORATION8.2.5. JOHNSON & JOHNSON (CERENOVUS)8.2.6. KANEKA CORPORATION8.2.7. MEDTRONIC INC8.2.8. MEMRY CORPORATION8.2.9. MICROPORT SCIENTIFIC CORPORATION8.2.10. PENUMBRA INC8.2.11. PHENOX GMBH8.2.12. RAPID MEDICAL8.2.13. SENSOME8.2.14. STRYKER CORPORATION8.2.15. TERUMO MEDICAL CORPORATION (MICROVENTION INC)

List of Tables

LIST OF TABLESTABLE 1: MARKET SNAPSHOT – NEUROVASCULAR DEVICESTABLE 2: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)TABLE 3: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)TABLE 4: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)TABLE 5: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)TABLE 6: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)TABLE 7: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)TABLE 8: LEADING PLAYERS OPERATING IN THE ASIA-PACIFIC NEUROVASCULAR DEVICES MARKETTABLE 9: LIST OF MERGERS & ACQUISITIONSTABLE 10: LIST OF PRODUCT LAUNCHES & DEVELOPMENTSTABLE 11: LIST OF PARTNERSHIPS & AGREEMENTSTABLE 12: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

List of Figures

LIST OF FIGURESFIGURE 1: KEY MARKET TRENDSFIGURE 2: PORTER’S FIVE FORCES ANALYSISFIGURE 3: OPPORTUNITY MATRIXFIGURE 4: VENDOR LANDSCAPEFIGURE 5: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY PRODUCT, IN 2020FIGURE 6: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIZATION DEVICES, 2021-2028 (IN $ MILLION)FIGURE 7: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY ACCESSORY DEVICES, 2021-2028 (IN $ MILLION)FIGURE 8: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY REVASCULARIZATION DEVICES, 2021-2028 (IN $ MILLION)FIGURE 9: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY THROMBECTOMY DEVICES, 2021-2028 (IN $ MILLION)FIGURE 10: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)FIGURE 11: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY APPLICATION, IN 2020FIGURE 12: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY ANEURYSM, 2021-2028 (IN $ MILLION)FIGURE 13: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY ISCHEMIC STROKE, 2021-2028 (IN $ MILLION)FIGURE 14: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY STENOSIS, 2021-2028 (IN $ MILLION)FIGURE 15: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2021-2028 (IN $ MILLION)FIGURE 16: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)FIGURE 17: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)FIGURE 18: CHINA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 19: JAPAN NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 20: AUSTRALIA & NEW ZEALAND NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 21: INDIA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 22: SOUTH KOREA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 23: THAILAND NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 24: INDONESIA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 25: VIETNAM NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)FIGURE 26: REST OF ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com

    医療・医薬の最新記事8件